| Primary |
| Product Used For Unknown Indication |
66.2% |
| Neuralgia |
6.0% |
| Pain |
4.5% |
| Neuropathy Peripheral |
4.0% |
| Epilepsy |
3.0% |
| Back Pain |
2.0% |
| Diabetic Neuropathy |
1.5% |
| Hiv Infection |
1.5% |
| Drug Use For Unknown Indication |
1.0% |
| Arthritis |
1.0% |
| Diabetic Nephropathy |
1.0% |
| Essential Tremor |
1.0% |
| Fibromyalgia |
1.0% |
| Insomnia |
1.0% |
| Nerve Block |
1.0% |
| Pain In Extremity |
1.0% |
| Polyneuropathy |
1.0% |
| Prostatomegaly |
1.0% |
| Trigeminal Neuralgia |
1.0% |
| Back Pain |
0.5% |
|
| Toxicity To Various Agents |
24.7% |
| Exposure Via Ingestion |
15.3% |
| Completed Suicide |
11.8% |
| Overdose |
5.9% |
| Wrong Drug Administered |
4.7% |
| Exposure During Pregnancy |
3.5% |
| Off Label Use |
3.5% |
| Death |
2.4% |
| Drug-induced Liver Injury |
2.4% |
| Erythema |
2.4% |
| Loss Of Consciousness |
2.4% |
| Mood Swings |
2.4% |
| Neuropathy Peripheral |
2.4% |
| Paraesthesia |
2.4% |
| Renal Impairment |
2.4% |
| Respiratory Arrest |
2.4% |
| Suicidal Ideation |
2.4% |
| Therapeutic Response Unexpected |
2.4% |
| Ventricular Tachycardia |
2.4% |
| Vomiting |
2.4% |
|
| Secondary |
| Product Used For Unknown Indication |
67.7% |
| Completed Suicide |
6.9% |
| Temporal Lobe Epilepsy |
3.7% |
| Central Pain Syndrome |
3.2% |
| Depression |
2.6% |
| Intentional Overdose |
2.6% |
| Status Epilepticus |
2.1% |
| Plasma Cell Myeloma |
1.6% |
| Porphyria Acute |
1.6% |
| Seizures |
1.6% |
| Neuralgia |
1.1% |
| Psychotic Disorder |
1.1% |
| Back Disorder |
0.5% |
| Back Pain |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Gait Disturbance |
0.5% |
| Gastritis |
0.5% |
| Hypertension |
0.5% |
| Insomnia |
0.5% |
| Mood Disorder Nos |
0.5% |
|
| Toxicity To Various Agents |
36.1% |
| Respiratory Arrest |
11.1% |
| Renal Impairment |
5.6% |
| Completed Suicide |
2.8% |
| Diarrhoea |
2.8% |
| Dry Throat |
2.8% |
| Epilepsy |
2.8% |
| Exposure During Pregnancy |
2.8% |
| Femoral Neck Fracture |
2.8% |
| Hallucination, Auditory |
2.8% |
| Hypersensitivity |
2.8% |
| Infarction |
2.8% |
| Mood Swings |
2.8% |
| Myoclonus |
2.8% |
| Oxygen Saturation Decreased |
2.8% |
| Platelet Count Decreased |
2.8% |
| Pneumonia |
2.8% |
| Poisoning |
2.8% |
| Pulmonary Embolism |
2.8% |
| Rash |
2.8% |
|
| Concomitant |
| Multiple Sclerosis |
26.4% |
| Plasma Cell Myeloma |
21.5% |
| Product Used For Unknown Indication |
9.6% |
| Depression |
5.1% |
| Gait Disturbance |
4.5% |
| Chronic Myeloid Leukaemia |
3.1% |
| Hepatitis C |
3.1% |
| Prophylaxis |
2.7% |
| Prostate Cancer Metastatic |
2.7% |
| Type 2 Diabetes Mellitus |
2.7% |
| Relapsing-remitting Multiple Sclerosis |
2.5% |
| Drug Use For Unknown Indication |
2.2% |
| Immunodeficiency Common Variable |
2.2% |
| Hypertension |
2.0% |
| Myelodysplastic Syndrome |
2.0% |
| Osteoporosis |
1.8% |
| Systemic Lupus Erythematosus |
1.8% |
| B-cell Lymphoma |
1.6% |
| Chronic Lymphocytic Leukaemia |
1.3% |
| Rheumatoid Arthritis |
1.1% |
|
| Vomiting |
11.5% |
| Pneumonia |
8.5% |
| Nausea |
6.7% |
| Vision Blurred |
6.7% |
| White Blood Cell Count Decreased |
6.7% |
| Visual Impairment |
5.5% |
| Pain In Extremity |
4.8% |
| Rash |
4.8% |
| Tremor |
4.8% |
| Urinary Tract Infection |
4.8% |
| Neuropathy Peripheral |
4.2% |
| Pain |
4.2% |
| Somnolence |
4.2% |
| Paraesthesia |
3.6% |
| Weight Increased |
3.6% |
| Fatigue |
3.0% |
| Malaise |
3.0% |
| Muscle Spasms |
3.0% |
| Muscular Weakness |
3.0% |
| Rectal Haemorrhage |
3.0% |
|
